Samsara BioCapital, LLC
Q2 2025 13F Holdings
- Locationpalo alto, CA
- Num holdings
29
- Value ($000)
$488,945
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001744967
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
SRRK SCHOLAR ROCK HLDG CORP | COM | 80706P103 | $198.81 M | 41 % | 5,612,896 | ||
MLYS MINERALYS THERAPEUTICS INC | COM | 603170101 | $76.78 M | 16 % | 5,674,916 | ||
SEPTERNA INC | COM | 81734D104 | $33.29 M | 7 % | 3,149,128 | ||
KALARIS THERAPEUTICS INC | COM | 482929106 | $30.57 M | 6 % | 11,448,081 | ||
NGNE NEUROGENE INC | COM | 64135M105 | $25.67 M | 5 % | 1,717,127 | ||
CRGX CARGO THERAPEUTICS INC | COM | 14179K101 | $18.19 M | 4 % | 4,415,689 | ||
UPSTREAM BIO INC | COM | 91678A107 | $15.85 M | 3 % | 1,443,231 | ||
ALMS ALUMIS INC | COM | 022307102 | $14.40 M | 3 % | 4,801,370 | ||
LENZ LENZ THERAPEUTICS INC | COM | 52635N103 | $10.05 M | 2 % | 343,012 | ||
PALVELLA THERAPEUTICS INC NE | COM | 697947109 | $7.66 M | 2 % | 339,743 |
Rows Per Page
10
- 10
- 50
- 100